These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32631784)

  • 1. RIPK2 NODs to XIAP and IBD.
    Topal Y; Gyrd-Hansen M
    Semin Cell Dev Biol; 2021 Jan; 109():144-150. PubMed ID: 32631784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling.
    Damgaard RB; Fiil BK; Speckmann C; Yabal M; zur Stadt U; Bekker-Jensen S; Jost PJ; Ehl S; Mailand N; Gyrd-Hansen M
    EMBO Mol Med; 2013 Aug; 5(8):1278-95. PubMed ID: 23818254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
    Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
    EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. XIAP mediates NOD signaling via interaction with RIP2.
    Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes.
    Steinle H; Ellwanger K; Mirza N; Briese S; Kienes I; Pfannstiel J; Kufer TA
    J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34152391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
    Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
    Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures.
    Ellwanger K; Briese S; Arnold C; Kienes I; Heim V; Nachbur U; Kufer TA
    Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31350258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
    Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
    EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity.
    Damgaard RB; Nachbur U; Yabal M; Wong WW; Fiil BK; Kastirr M; Rieser E; Rickard JA; Bankovacki A; Peschel C; Ruland J; Bekker-Jensen S; Mailand N; Kaufmann T; Strasser A; Walczak H; Silke J; Jost PJ; Gyrd-Hansen M
    Mol Cell; 2012 Jun; 46(6):746-58. PubMed ID: 22607974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch,
    Peng XY; Wang KL; Li L; Li B; Wu XY; Zhang ZW; Li N; Liu LH; Nie P; Chen SN
    Front Immunol; 2024; 15():1374368. PubMed ID: 38715616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
    Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.
    Goncharov T; Hedayati S; Mulvihill MM; Izrael-Tomasevic A; Zobel K; Jeet S; Fedorova AV; Eidenschenk C; deVoss J; Yu K; Shaw AS; Kirkpatrick DS; Fairbrother WJ; Deshayes K; Vucic D
    Mol Cell; 2018 Feb; 69(4):551-565.e7. PubMed ID: 29452636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
    Zhang W; Wang Y
    Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local receptor-interacting protein kinase 2 inhibition mitigates house dust mite-induced asthma.
    Alvarez-Simon D; Ait Yahia S; Audousset C; Fanton d'Andon M; Chamaillard M; Gomperts Boneca I; Tsicopoulos A
    Eur Respir J; 2024 Oct; 64(4):. PubMed ID: 39117431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nucleotide-binding oligomerization domain 1 (NOD1) and its variants in human cytomegalovirus control in vitro and in vivo.
    Fan YH; Roy S; Mukhopadhyay R; Kapoor A; Duggal P; Wojcik GL; Pass RF; Arav-Boger R
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7818-E7827. PubMed ID: 27856764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.
    Rivoal M; Dubuquoy L; Millet R; Leleu-Chavain N
    J Med Chem; 2023 Nov; 66(21):14391-14410. PubMed ID: 37857324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
    Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
    Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel disease.
    Ermann J; Matmusaev M; Haley EK; Braun C; Jost F; Mayer-Wrangowski S; Hsiao P; Ting N; Li L; Terenzio D; Chime J; Lukas S; Patnaude L; Panzenbeck M; Csordas D; Zheng J; Mierz D; Simpson T; King FJ; Klimowicz AP; Mbow ML; Fine JS; Miller CA; Fogal SE; Byrne FR
    Am J Physiol Gastrointest Liver Physiol; 2021 Nov; 321(5):G500-G512. PubMed ID: 34494462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
    Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
    Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.